SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-18-000010
Filing Date
2018-05-15
Accepted
2018-05-15 16:31:45
Documents
66
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sls-20180331x10q.htm 10-Q 805806
2 EXHIBIT 10.24 sls20180331ex1024.htm EX-10.24 176888
3 EXHIBIT 31.1 sls20180331ex311.htm EX-31.1 9022
4 EXHIBIT 31.2 sls20180331ex312.htm EX-31.2 9049
5 EXHIBIT 32.1 sls20180331ex321.htm EX-32.1 18189
12 sellas-logoa03.jpg GRAPHIC 30719
  Complete submission text file 0001390478-18-000010.txt   5050079

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gale-20180331.xml EX-101.INS 855841
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20180331.xsd EX-101.SCH 51118
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20180331_cal.xml EX-101.CAL 58308
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20180331_def.xml EX-101.DEF 226723
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20180331_lab.xml EX-101.LAB 579226
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20180331_pre.xml EX-101.PRE 348464
Mailing Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017
Business Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017 (813) 864-4523
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 18837051
SIC: 2834 Pharmaceutical Preparations